American Thyroid Association Statement: Breast Cancer and Thyroid Hormone Therapy
Authors: COLUM A. GORMAN
Journal: Annals of Internal Medicine (1977)

Special Article1 April 1977American Thyroid Association Statement: Breast Cancer and Thyroid Hormone TherapyEDUCATION COMMITTEE, AMERICAN THYROID ASSOCIATION, COLUM A. GORMAN, M.B., B.CH. (CHAIRMAN), DAVID V. BECKER, M.D., FRANCIS S. GREENSPAN, M.D., RICHARD P. LEVY, M.D., JACK H. OPPENHEIMER, M.D., RICHARD S. RIVLIN, M.D., JACOB ROBBINS, M.D., WILLARD P. VANDERLAAN, M.D.EDUCATION COMMITTEESearch for more papers by this author, AMERICAN THYROID ASSOCIATIONSearch for more papers by this author, COLUM A. GORMAN, M.B., B.CH. (CHAIRMAN)Search for more papers by this author, DAVID V. BECKER, M.D.Search for more papers by this author, FRANCIS S. GREENSPAN, M.D.Search for more papers by this author, RICHARD P. LEVY, M.D.Search for more papers by this author, JACK H. OPPENHEIMER, M.D.Search for more papers by this author, RICHARD S. RIVLIN, M.D.Search for more papers by this author, JACOB ROBBINS, M.D.Search for more papers by this author, WILLARD P. VANDERLAAN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-86-4-502 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAmong patients undergoing mammography at a hospital in Detroit, Michigan, the prevalence of breast cancer was higher in women receiving thyroid hormone therapy than in those who were not (1). The prevalence of breast cancer was said to increase with longer duration of thyroid hormone treatment, particularly in nulliparous women. After this report appeared and was widely publicized by the news media, many patients have expressed concern that the thyroid hormone they are taking may be dangerous, and they have inquired as to whether such treatment should be stopped.The American Thyroid Association, whose membership comprises physicians and basic scientists...References1. KAPDIWOLFE CJ: Breast Cancer. Relationship to thyroid supplements for hypothyroidism. JAMA 236:1124-1127, 1976 CrossrefMedlineGoogle Scholar2. BEATSON G: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 2:162, 1896 CrossrefGoogle Scholar3. UTIGER R: Thyrotrophin radioimmunoassay: another test of thyroid function. Ann Intern Med 74:627-629, 1971 LinkGoogle Scholar4. MITTRAHAYWARD IJ: Hypothalamic-pituitary-thyroid axis in breast cancer. Lancet 1:885-888, 1974 CrossrefMedlineGoogle Scholar5. WARTOFSKYDIMONDNOEL LRG: Effect of acute increases in serum triiodothyronine on TSH and prolactin responses to TRH, and estimates of pituitary stores of TSH and prolactin in normal subjects and in patients with primary hypothyroidism. J Clin Endocrinol Metab 42:443-458, 1976 CrossrefMedlineGoogle Scholar6. MITTRAHAYWARDMCNEILLY IJA: Hypothalamic-pituitary-prolactin axis in breast cancer. Lancet 1:889-891, 1974 CrossrefMedlineGoogle Scholar7. EDITORIAL: The thyroid, prolactin, and breast cancer. Lancet 1:908-909, 1974 MedlineGoogle Scholar8. FISHMANHELLMANZUMOFF JLB: Influence of thyroid hormone on estrogen metabolism in man. J Clin Endocrinol Med 22:389-392, 1962 CrossrefGoogle Scholar9. LEMON H: Endocrine influences on human mammary cancer formation. A critique. Cancer 23:781-790, 1969 CrossrefMedlineGoogle Scholar10. GALLAGHERHELLMANBRADLOW TLH: The effects of thyroid hormones on the metabolism of steroids. Ann NY Acad Sci 86:605-611, 1960 CrossrefMedlineGoogle Scholar11. DOLL R: The geographical distribution of cancer. Br J Cancer 23:1-8, 1969 CrossrefMedlineGoogle Scholar12. STADEL B: Dietary iodine and risk of breast, endometrial, and ovarian cancer. Lancet 1:890-891, 1976 CrossrefMedlineGoogle Scholar13. FINLEYBOGARDUS JG: Breast cancer and thyroid disease. Q Rev Surg Obstet Gynecol 17:139-147, 1960 MedlineGoogle Scholar14. ESKIN B: Iodine metabolism and breast cancer. Trans NY Acad Sci 32:911-947, 1970 CrossrefMedlineGoogle Scholar15. MITTRAPERRINKUMAOKA IJS: Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. Br Med J 1:257-259, 1976 CrossrefMedlineGoogle Scholar16. MARUCHIANNEGERSKURLAND NJL: Hashimoto's thyroiditis and breast cancer. Mayo Clin Proc 51:263-265, 1976 MedlineGoogle Scholar17. ITOHMARUCHI KN: Breast cancer in patients with Hashimoto's thyroiditis. Lancet 2:1119-1121, 1975 CrossrefMedlineGoogle Scholar18. ELLERKER A: Thyroid disorders and breast cancer. A casual connection? Med Press 235:280-282, 1956 Google Scholar19. LOESER A: A new therapy for prevention of post-operative recurrences in genital and breast cancer. Br Med J 2:1380-1383, 1954 CrossrefMedlineGoogle Scholar20. REPERT R: Breast carcinoma study: Relationship to thyroid disease and diabetes. J Mich State Med Soc 51:1315-1316, 1952 MedlineGoogle Scholar21. EDELSTYNLYONSWELBOURN GAR: Thyroid function in patients with mammary cancer. Lancet 1:670-671, 1958 CrossrefMedlineGoogle Scholar22. STOLL B: Breast cancer and hypothyroidism. Cancer 18:1431-1436, 1965 CrossrefMedlineGoogle Scholar23. SCHOTTENFELD D: The relationship of breast cancer to thyroid disease. J Chronic Dis 21:303-313, 1968 CrossrefMedlineGoogle Scholar24. MOOSSAEVANSBREWER ADA: Thyroid status and breast cancer. Reappraisal of an old relationship. Ann R Coll Surg Engl 53:178-188, 1973 MedlineGoogle Scholar25. WANEBOBENUARAWSON HRR: Neoplastic disease and thyrotoxicosis. Cancer 19:1523-1526, 1966 CrossrefMedlineGoogle Scholar26. CHALSTREYBENJAMIN LB: High incidence of breast cancer in thyroid cancer patients. Br J Cancer 20:670-675, 1966 CrossrefMedlineGoogle Scholar27. KELLEN J: Brief communication: effect of hypothyroidism on induction of mammary tumors in rats by 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 48:1901-1904, 1972 MedlineGoogle Scholar28. BAKERYAFFE DA: The influence of thyroid stimulation on the incidence of 3-methylcholanthrene-induced tumors. Cancer Res 35:528-530, 1975 MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByThe antigenic link between thyroid autoimmunity and breast cancerAmerican Thyroid Association Guidelines and Statements: Past, Present, and FutureHORMONAL PROFILES IN WOMEN WITH BREAST CANCERThyroid Disease and Breast CancerHypothyroidism and Tumor RegressionThyroid function in women with breast cancerEstrogen-2-hydroxylase in the ratPlasma triiodothyronine concentrations in breast cancer 1 April 1977Volume 86, Issue 4Page: 502-503KeywordsBreast cancerCancer treatmentHormonal therapyMammographyScientistsThyroidThyroid hormones Issue Published: 1 April 1977 PDF DownloadLoading ...